N

Neurogene Inc.

40 employees

Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.

Basic info

Industry

biotechnology

Sectors

Biotechnology

Date founded

2018

Funding rounds raised

Total raised

$69M

from 2 investors over 2 rounds

N

Neurogene Inc. raised $69M on February 12, 2019

Investors: Samsara BioCapital and Redmile Group

FAQ